Name: REPLICEL LIFE SCIENCES INC. Deferred Tax Expense Income 2015-2022
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

REPLICEL LIFE SCIENCES INC. Deferred Tax Expense Income

REPLICEL LIFE SCIENCES INC. reported Deferred Tax Expense Income of CAD 0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-05-02.

Discontinued › Expense Statement › Operating Expenses

ifrs-full:DeferredTaxExpenseIncome · last filed 2023-05-02

Period end	Deferred Tax Expense Income 12 month
2022-12-31	0.00 CAD 20-F · filed 2023-05-02
2021-12-31	0.00 CAD 20-F · filed 2023-05-02
2020-12-31	0.00 CAD 20-F · filed 2023-05-02
2019-12-31	0.00 CAD 20-F/A · filed 2022-09-13
2018-12-31	0.00 CAD 20-F/A · filed 2022-09-13
2017-12-31	0.00 CAD 20-F/A · filed 2021-03-31
2016-12-31	0.00 CAD 20-F · filed 2019-04-30
2015-12-31	0.00 CAD 20-F · filed 2018-05-11